Slater Technology Fund invests $500K in MindImmune Therapeutics

MindImmune Therapeutics is a South Kingstown-based pharmaceutical startup./ LOGO COURTESY MINDIMMUNE
MindImmune Therapeutics is a South Kingstown-based pharmaceutical startup.
PROVIDENCE – MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. MindImmune Therapeutics is treating central nervous system diseases such as Alzheimer’s and Huntington’s disease, as well as pain and psychiatric disorders, by developing drugs targeting the immune system. “Research advances over the past…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -